The executive board and supervisory board of Evonik Industries AG (hereinafter the company) hereby submit the following declaration pursuant to section 161 of the GermanStock Corporation Act..
... with EvonikCorporation (“EVONIK”), a global leader in high‑performance polymers, to manufacture the Company’s proprietary silicon nitride–PEEK compound (SiN/PEEK) (U.S.
SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company, today announced that it has signed a supply agreement with EvonikCorporation ("EVONIK"), ...
November 17, 2025 Evonik and InVitria partner to expand access to animal-free albumin for biopharma innovation ... Evonik will distribute InVitria's blood-free recombinant human serum albumin (rHSA) portfolio to its biopharma customers.
Kelyniam received a exclusive U.S. license from Evonik to market VESTAKEEP� Fusion, a bi-calcium phosphate-infused PEEK material, for cranial implants ... .
). Evonik. CompanyPresentation Q3 2025. Evonik at a glance. Financials Q3 2025 ... €15.2 bn ... Adj ... EVONIK IS INDUSTRY'S SUPERFORCE ... Evonik Industries AG published this content on November 06, 2025, and is solely responsible for the information contained herein.
Specialty chemicals company Evonik has strong confidence in the long-term prospects of the China market, focusing not only on sales growth but also on increasing profits, a senior executive said.